Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex

Astrocytes control tissue equilibrium and hence define the homoeostasis and function of the CNS (central nervous system). Being principal homoeostatic cells, astroglia are fundamental for various forms of neuropathology, including AD (Alzheimer's disease). AD is a progressive neurodegenerative...

Full description

Bibliographic Details
Main Authors: Magdalena Kulijewicz-Nawrot, Eva Syková, Alexander Chvátal, Alexei Verkhratsky, José J. Rodríguez
Format: Article
Language:English
Published: SAGE Publishing 2013-09-01
Series:ASN Neuro
Online Access:https://doi.org/10.1042/AN20130017
id doaj-0bce1bcdbdbf46ba879ff64c926700b2
record_format Article
spelling doaj-0bce1bcdbdbf46ba879ff64c926700b22020-11-25T02:22:15ZengSAGE PublishingASN Neuro1759-09141759-90912013-09-01510.1042/AN2013001710.1042_AN20130017Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal CortexMagdalena Kulijewicz-Nawrot0Eva Syková1Alexander Chvátal2Alexei Verkhratsky3José J. Rodríguez4 Institute of Experimental Medicine, ASCR, Videnska 1083, 142 20 Prague, Czech Republic Department of Neuroscience and Center for Cell Therapy and Tissue Repair, Charles University, Second Medical Faculty, Prague, Czech Republic Institute of Experimental Medicine, ASCR, Videnska 1083, 142 20 Prague, Czech Republic Department of Neurosciences, University of the Basque Country UPV/EHU, 48940 Leioa, Spain and CIBERNED Department of Neurosciences, University of the Basque Country UPV/EHU, 48940 Leioa, Spain and CIBERNEDAstrocytes control tissue equilibrium and hence define the homoeostasis and function of the CNS (central nervous system). Being principal homoeostatic cells, astroglia are fundamental for various forms of neuropathology, including AD (Alzheimer's disease). AD is a progressive neurodegenerative disorder characterized by the loss of cognitive functions due to specific lesions in mnesic-associated regions, including the mPFC (medial prefrontal cortex). Here, we analyzed the expression of GS (glutamine synthetase) and GLT-1 (glutamate transporter-1) in astrocytes in the mPFC during the progression of AD in a triple-transgenic mouse model (3xTg-AD). GS is an astrocyte-specific enzyme, responsible for the intracellular conversion of glutamate into glutamine, whereas the removal of glutamate from the extracellular space is accomplished mainly by astroglia-specific GLT-1. We found a significant decrease in the numerical density (Nv, cells/mm 3 ) of GS-positive astrocytes from early to middle ages (1–9 months; at the age of 1 month by 17%, 6 months by 27% and 9 months by 27% when compared with control animals) in parallel with a reduced expression of GS (determined by Western blots), which started at the age of 6 months and was sustained up to 12 months of age. We did not, however, find any changes in the expression of GLT-1, which implies an intact glutamate uptake mechanism. Our results indicate that the decrease in GS expression may underlie a gradual decline in the vital astrocyte-dependent glutamate–glutamine conversion pathway, which in turn may compromise glutamate homoeostasis, leading towards failures in synaptic connectivity with deficient cognition and memory.https://doi.org/10.1042/AN20130017
collection DOAJ
language English
format Article
sources DOAJ
author Magdalena Kulijewicz-Nawrot
Eva Syková
Alexander Chvátal
Alexei Verkhratsky
José J. Rodríguez
spellingShingle Magdalena Kulijewicz-Nawrot
Eva Syková
Alexander Chvátal
Alexei Verkhratsky
José J. Rodríguez
Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
ASN Neuro
author_facet Magdalena Kulijewicz-Nawrot
Eva Syková
Alexander Chvátal
Alexei Verkhratsky
José J. Rodríguez
author_sort Magdalena Kulijewicz-Nawrot
title Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
title_short Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
title_full Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
title_fullStr Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
title_full_unstemmed Astrocytes and Glutamate Homoeostasis in Alzheimer's Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex
title_sort astrocytes and glutamate homoeostasis in alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex
publisher SAGE Publishing
series ASN Neuro
issn 1759-0914
1759-9091
publishDate 2013-09-01
description Astrocytes control tissue equilibrium and hence define the homoeostasis and function of the CNS (central nervous system). Being principal homoeostatic cells, astroglia are fundamental for various forms of neuropathology, including AD (Alzheimer's disease). AD is a progressive neurodegenerative disorder characterized by the loss of cognitive functions due to specific lesions in mnesic-associated regions, including the mPFC (medial prefrontal cortex). Here, we analyzed the expression of GS (glutamine synthetase) and GLT-1 (glutamate transporter-1) in astrocytes in the mPFC during the progression of AD in a triple-transgenic mouse model (3xTg-AD). GS is an astrocyte-specific enzyme, responsible for the intracellular conversion of glutamate into glutamine, whereas the removal of glutamate from the extracellular space is accomplished mainly by astroglia-specific GLT-1. We found a significant decrease in the numerical density (Nv, cells/mm 3 ) of GS-positive astrocytes from early to middle ages (1–9 months; at the age of 1 month by 17%, 6 months by 27% and 9 months by 27% when compared with control animals) in parallel with a reduced expression of GS (determined by Western blots), which started at the age of 6 months and was sustained up to 12 months of age. We did not, however, find any changes in the expression of GLT-1, which implies an intact glutamate uptake mechanism. Our results indicate that the decrease in GS expression may underlie a gradual decline in the vital astrocyte-dependent glutamate–glutamine conversion pathway, which in turn may compromise glutamate homoeostasis, leading towards failures in synaptic connectivity with deficient cognition and memory.
url https://doi.org/10.1042/AN20130017
work_keys_str_mv AT magdalenakulijewicznawrot astrocytesandglutamatehomoeostasisinalzheimersdiseaseadecreaseinglutaminesynthetasebutnotinglutamatetransporter1intheprefrontalcortex
AT evasykova astrocytesandglutamatehomoeostasisinalzheimersdiseaseadecreaseinglutaminesynthetasebutnotinglutamatetransporter1intheprefrontalcortex
AT alexanderchvatal astrocytesandglutamatehomoeostasisinalzheimersdiseaseadecreaseinglutaminesynthetasebutnotinglutamatetransporter1intheprefrontalcortex
AT alexeiverkhratsky astrocytesandglutamatehomoeostasisinalzheimersdiseaseadecreaseinglutaminesynthetasebutnotinglutamatetransporter1intheprefrontalcortex
AT josejrodriguez astrocytesandglutamatehomoeostasisinalzheimersdiseaseadecreaseinglutaminesynthetasebutnotinglutamatetransporter1intheprefrontalcortex
_version_ 1724862417210441728